Quantum Cyber N.V. (QUCY): Capital Expenditures
$1.2K
Year ended 2025-12-31
$137.5K
Trailing 12 months to 2026-06-30
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.2K | -98.8% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $104.9K | n/a | 2026-03-31, From 2024-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $1.2K | -98.8% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $55.0K | -73.9% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $0 | -100.0% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $20.0K | n/a |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $442.3K | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $22.0K | -67.2% |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $0 | n/a |
| Polomar Health Services, Inc. (PMHS) | 2024-12-31 | $90.9K | n/a |
| Scienture Holdings, Inc. (SCNX) | 2024-12-31 | $12.0K | n/a |
Compare QUCY, SLN, YARW, MREO side by side · Screen every company in Pharmaceutical Preparations ↗